Skip to main content
. 2015 Mar 8;6(8):5615–5633. doi: 10.18632/oncotarget.3479

Figure 5. Biological and prognostic impact of CD5 expression in the validation DLBCL cohort.

Figure 5

(A-B) CD5 expression was correlated with significantly poorer OS and PFS in the overall DLBCL cohort; (C-D) CD5 expression was correlated with Bcl-2 overexpression and decreased SSBP2 expression; (E-F) The prognostic significance of CD5+ was independent of Bcl-2 overexpression; (G-H) The prognostic significance of CD5+ in the validation DLBCL cohort depended on loss of SSBP2 expression; (I-L) The prognostic significance of CD5+ was independent of the IPI.